| 1 |
33432521 | Co-delivery of doxorubicin and SIS3 by folate-targeted polymeric micelles for overcoming tumor multidrug resistance. | 2022 Jan |
1 |
| 2 |
28300564 | Contrasting roles of the ABCG2 Q141K variant in prostate cancer. | 2017 May 1 |
3 |
| 3 |
24979295 | Associations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese population. | 2014 Oct |
3 |
| 4 |
22248732 | Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. | 2012 Apr 15 |
1 |
| 5 |
26105097 | Folate transporter expression decreases in the human placenta throughout pregnancy and in pre-eclampsia. | 2012 Apr |
2 |
| 6 |
19277036 | Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib. | 2009 Apr 7 |
4 |
| 7 |
18086804 | Progesterone acts via progesterone receptors A and B to regulate breast cancer resistance protein expression. | 2008 Mar |
1 |
| 8 |
18623116 | Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells. | 2008 Oct 1 |
7 |
| 9 |
17333344 | Molecular basis of antifolate resistance. | 2007 Mar |
2 |
| 10 |
16362298 | Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment. | 2006 Jul |
4 |
| 11 |
15657365 | Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mechanism of adaptation to short-term folate deprivation. | 2005 Apr |
24 |
| 12 |
15047700 | Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis. | 2004 Jun 11 |
12 |
| 13 |
12874005 | Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. | 2003 Jul 15 |
2 |